HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemotherapy in canine acute megakaryoblastic leukemia: a case report and review of the literature.

Abstract
Acute myeloid leukemia (AML) in dogs is a rare disease with poor prognosis. In most subjects, palliative treatment or euthanasia is performed. A 3.5-year-old male castrated labrador with AML-M7, which was treated with induction polychemotherapy (8 cycles) using vincristine (0.5 mg/m(2)/cycle), daunorubicin (20 mg/m(2)/cycle), cytosine arabinoside (ARA-C, 100 mg/m(2)/cycle) and prednisolone (1 mg/kg/day) is reported. Treatment was well tolerated and complete remission was achieved. Postinduction chemotherapy consisted of ARA-C, daunorubicin and prednisolone. After 3, 5 and 18 months, the subject relapsed. Each relapse was treated with ARA-C (up to 1,000 mg/m(2)) and etoposide or daunorubicin. Again, no severe side-effects occurred and the disease was controlled, with 37 chemotherapy-cycles (ARA-C, 3 x 1,000 mg/m(2)/cycle), for 24 months. Based on a literature-search, this is the first report documenting a long-term response of canine AML, probably resulting from the high-dose ARA-C. Clinical trials using high-dose ARA-C are now required to confirm antileukemic efficacy in canine leukemias.
AuthorsMichael Willmann, Leonhard Müllauer, Ilse Schwendenwein, Birgitt Wolfesberger, Miriam Kleiter, Maximilian Pagitz, Emir Hadzijusufovic, Sarina Shibly, Martin Reifinger, Johann G Thalhammer, Peter Valent
JournalIn vivo (Athens, Greece) (In Vivo) 2009 Nov-Dec Vol. 23 Issue 6 Pg. 911-8 ISSN: 0258-851X [Print] Greece
PMID20023232 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Cytarabine
  • Vincristine
  • Etoposide
  • Prednisolone
  • Daunorubicin
Topics
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Bone Marrow Cells (drug effects, pathology)
  • Cytarabine (administration & dosage)
  • Daunorubicin (administration & dosage)
  • Dog Diseases (drug therapy)
  • Dogs
  • Etoposide (administration & dosage)
  • Leukemia, Megakaryoblastic, Acute (drug therapy, pathology, veterinary)
  • Male
  • Prednisolone (administration & dosage)
  • Remission Induction
  • Secondary Prevention
  • Vincristine (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: